Institutional investors hold a majority ownership of ZTS through the 93.71% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended March 2015, these large investors purchased a net $4.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ETHENEA INDEPENDENT INVESTORS SA Bought 200.0 Thousand shares of Zoetis Inc